Answer
No, ioflupane (DaTSCAN) is not recommended in moderate to severe renal or hepatic impairment because formal studies in patients with significant impairment have not been conducted and data are absent.
Sources for this answer
- DaTSCAN 74 MBq/ml solution for injectionGE Healthcare Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked